Acquisition · Shareholders have voted
Sanara MedTech Inc. acquisition by MiMedx Group, Inc.: what happens to stock options and RSUs
MiMedx is acquiring Sanara MedTech for $33.00 in cash plus 0.4735 MiMedx share per share; shareholders voted on September 30, 2026. All restricted stock, vested or not, receives the merger consideration, and all options, vested or not, are cashed out for their spread.
- Buyer
- MiMedx Group, Inc.
- What holders receive
- $33.00 cash plus 0.4735 MiMedx share per share
- Agreement signed
- July 29, 2026
- Shareholder vote
- September 30, 2026
- Expected closing
- Not stated in the filing
How equity awards are treated
| Stock options | All options, vested or not, cashed out for the spread over the combined consideration value |
|---|---|
| Unvested RSUs | All restricted stock, vested or not, receives the full merger consideration |
What this means for your taxes
- Shares you own outright get cash, stock or both. Even in a deal that is otherwise tax-free, the cash part is generally taxable to the extent of your gain.
- Options and RSUs paid in cash run through payroll as wages: income tax plus Social Security and Medicare. Employers usually withhold federal income tax at a flat 22%, or 37% on supplemental wages above $1 million in the calendar year (IRS Publication 15). If your top bracket is higher than 22%, withholding can fall short and you may owe more when you file; an estimated payment avoids a surprise.
- Incentive stock options that are cancelled for cash generally do not get ISO treatment: the payment is taxed like wages, the same as non-qualified options.
- ESPP shares sold in the deal within 2 years of the offering date or 1 year of purchase are a disqualifying disposition: part of the gain is taxed as ordinary income.
General rules, not advice for your situation. Your award agreement and the merger agreement control. Full guide: stock options and RSUs in an acquisition →
Get updates on the Sanara MedTech Inc. deal
We'll email you when shareholders vote, when the deal closes, and if terms change.
One email per alert. Unsubscribe any time. We never sell your address.
Holding a large position in one stock?
Get our checklist of the ways people diversify a concentrated position (staged sales under a 10b5-1 plan, exchange funds, collars, gifting appreciated shares) and the tax trade-off of each. One email, plus alerts for this company.
One email per alert. Unsubscribe any time. We never sell your address.
Source
From the company's SEC filing: DEFM14A (accession 0001213900-26-097669). Last checked against the filing on November 19, 2026. Found an error? Corrections are made the same day; see how we check.
Questions
What will Sanara MedTech Inc. shareholders receive?
Under the merger agreement, holders receive $33.00 cash plus 0.4735 MiMedx share per share.
What happens to Sanara MedTech Inc. stock options and RSUs?
Stock options: All options, vested or not, cashed out for the spread over the combined consideration value; Unvested RSUs: All restricted stock, vested or not, receives the full merger consideration
When will the deal close?
The filing does not give a specific closing date; closing depends on approvals.